Skip to content

Author

Y.-H. Shen

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

[Efficacy of maintenance therapy with or without pembrolizumab in patients with advanced gastric cancer after first-line chemotherapy].

In patients with advanced gastric cancer after first-line chemotherapy for disease control, there is no statistically significant difference in the efficacy of maintenance therapy with or without Pembrolizumab combined with chemotherapy, and it can reduce the cumulative toxicity caused by continuous chemotherapy.

B. Shi, P. Hu, M. Bi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.